Charles W. Serby

Statistics

Publications

Citations

1.9K

H-Index

Active since

1981

Affiliations

Boehringer Ingelheim (United States)(Current)

University Medical Center New Orleans

Tulane University

UCLA Medical Center

Charles W. Serby is an author at Boehringer Ingelheim (United States) specializing in pharmacotherapy, chronic obstructive pulmonary disease, and pharmacy.

Publications per year

1981–2002

Publications

A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease

Richard Casaburi, Donald A. Mahler, Paul Jones et al. · European Respiratory Journal · 2002 · 886 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +17

Long-Acting Bronchodilation with Once-Daily Dosing of Tiotropium (Spiriva) in Stable Chronic Obstructive Pulmonary Disease

Michael R. Littner, Jonathan Ilowite, Donald P. Tashkin et al. · American Journal of Respiratory and Critical Care Medicine · 2000 · 220 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

The Spirometric Efficacy of Once-Daily Dosing With Tiotropium in Stable COPD

Richard Casaburi, Dick D. Briggs, James F. Donohue et al. · CHEST Journal · 2000 · 198 citations

Pharmacy, Pharmacotherapy, Pulmonary Function Testing +15

Pharmacoeconomic Evaluation of a Combination of Ipratropium Plus Albuterol Compared With Ipratropium Alone and Albuterol Alone in COPD

Mitchell Friedman, Charles W. Serby, Shailendra Menjoge et al. · CHEST Journal · 1999 · 176 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +12

Extended Therapy With Ipratropium Is Associated With Improved Lung Function in Patients With COPD

Stephen I. Rennard, Charles W. Serby, Mo Ghafouri et al. · CHEST Journal · 1996 · 130 citations

Medicine, Pharmacotherapy, Pulmonary Function Testing +9

1–5 of 9